Clinical trials with allergen products--statistical considerations
Volkers, P.
Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 95: 172-180; Discussion 181
2006
ISSN/ISBN: 0936-8671 PMID: 17393737 Document Number: 601637
Document emailed within 1 workday
Related Documents
Sylvester, R.; Collette, L. 1999: Statistical considerations of chemoprevention clinical trials in prostate cancer European Urology 35(5-6): 519-522Schmale, A.H. 1980: Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part I. Introduction Cancer Treatment Reports 64(2-3): 441-443
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Rabin, R.L.; Slater, J.E.; Lachenbruch, P.; Pastor, R.W. 2003: Sample size considerations for establishing clinical bioequivalence of allergen formulations Arbeiten aus dem Paul-Ehrlich-Institut Zu Frankfurt A.M 94: 24-33
Goadsby, P.J. 2003: Statistical methods in clinical trials Medical Journal of Australia 179(2): 119-20; Author Reply 120
Hamada, C. 2015: Statistical Viewpoints on Designing Investigator Initiated Clinical Trials Nihon Geka Gakkai Zasshi 116(3): 176-180
Röthig, H.J. 1994: Clinical trials of gene/biotechnology products Methods and Findings in Experimental and Clinical Pharmacology 16(7): 539-544
Villa, R. 1979: Clinical considerations and comparative statistical findings on perinatal mortality in 2 quadrenniums Minerva Pediatrica 31(8): 633-639
O'Brien, F.B.; Stewart, W.C.; Sturtevant, F.M. 1983: Incidence of pelvic inflammatory disease in clinical trials with Cu-7 (intrauterine copper contraceptive): a statistical analysis Contraception 27(2): 111-122
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Parashos, P.J.; Dugan, W.M.; Fry, M.W. 1987: Continuous infusion metoclopramide: clinical trials, pharmacokinetic considerations and cost-effectiveness Progress in Clinical and Biological Research 248: 303-311
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Addy, M. 1995: Evaluation of clinical trials of agents and procedures to prevent caries and periodontal disease: choosing products and recommending procedures International Dental Journal 45(3): 185-196
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570